11.50
1.50%
+0.17
アフターアワーズ:
11.46
-0.04
-0.35%
Roivant Sciences Ltd (ROIV) 最新ニュース
Critical Insights From Roivant Sciences Analyst Ratings: What You Need To Know
Benzinga
Where Roivant Sciences Stands With Analysts
Benzinga
The Analyst Landscape: 4 Takes On Roivant Sciences
Benzinga
Roivant to Report Financial Results for the Third Quarter Ended December 31, 2023, and Provide Business Update on Tuesday, February 13, 2024
GlobeNewswire Inc.
Analyst Highlights Aclaris Therapeutics' Encouraging Efficacy For Eczema Candidate, But Cautions On Data Variations
Benzinga
Assessing Roivant Sciences: Insights From 5 Financial Analysts
Benzinga
Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
GlobeNewswire Inc.
FedEx Posts Downbeat Earnings, Joins Steelcase, argenx And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Benzinga
Analyst Ratings for Roivant Sciences
Benzinga
大文字化:
|
ボリューム (24 時間):